CA964193A - Injectable compositions containing salts of l-tetramisole - Google Patents

Injectable compositions containing salts of l-tetramisole

Info

Publication number
CA964193A
CA964193A CA088,685A CA88685A CA964193A CA 964193 A CA964193 A CA 964193A CA 88685 A CA88685 A CA 88685A CA 964193 A CA964193 A CA 964193A
Authority
CA
Canada
Prior art keywords
tetramisole
compositions containing
injectable compositions
containing salts
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA088,685A
Other languages
English (en)
Other versions
CA88685S (en
Inventor
Bruce A. Forsyth
David E. Pryor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orica Ltd
Original Assignee
Imperial Chemical Industries of Australia and New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries of Australia and New Zealand Ltd filed Critical Imperial Chemical Industries of Australia and New Zealand Ltd
Application granted granted Critical
Publication of CA964193A publication Critical patent/CA964193A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA088,685A 1969-07-21 1970-07-21 Injectable compositions containing salts of l-tetramisole Expired CA964193A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU5831169 1969-07-21

Publications (1)

Publication Number Publication Date
CA964193A true CA964193A (en) 1975-03-11

Family

ID=3743604

Family Applications (1)

Application Number Title Priority Date Filing Date
CA088,685A Expired CA964193A (en) 1969-07-21 1970-07-21 Injectable compositions containing salts of l-tetramisole

Country Status (9)

Country Link
US (1) US3670086A (de)
BE (1) BE753710A (de)
CA (1) CA964193A (de)
DE (1) DE2036114C3 (de)
FR (1) FR2059541B1 (de)
GB (1) GB1287673A (de)
IE (1) IE34373B1 (de)
NL (1) NL165653C (de)
ZA (1) ZA704419B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096271A (en) * 1977-08-03 1978-06-20 American Cyanamid Company Slow release injectable formulations of tetramisole and derivatives in benzyl benzoate
JP2007502293A (ja) 2003-08-12 2007-02-08 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ含有化合物
EP1658076B1 (de) 2003-08-27 2013-03-06 3M Innovative Properties Company Aryloxy- und arylalkylenoxy-substituierte imidazochinoline
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AR046046A1 (es) 2003-10-03 2005-11-23 3M Innovative Properties Co Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
BRPI0416936A (pt) 2003-11-25 2007-01-16 3M Innovative Properties Co sistemas de anel de imidazo substituìdos e métodos
EP1701955A1 (de) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl- und arylalkinylsubstituierte imidazochinoline
EP1699788A2 (de) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazochinolinyl-, imidazopyridinyl- und imidazonaphthyridinylsulfonamide
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006009832A1 (en) * 2004-06-18 2006-01-26 3M Innovative Properties Company Substituted imidazo ring systems and methods
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
JP2008526757A (ja) * 2004-12-30 2008-07-24 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調節剤製剤および方法
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
US9248127B2 (en) 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
EP1846405A2 (de) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxim- und hydroxylaminsubstituierte imidazo-4,5-c-ringverbindungen und verfahren
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
CN104906036A (zh) * 2015-06-12 2015-09-16 重庆市畜牧科学院 阿魏酸左旋咪唑注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (de) * 1964-05-11
AU421744B2 (en) * 1967-08-24 1972-02-24 I. C. I. Australia Limited Chemical process

Also Published As

Publication number Publication date
IE34373L (en) 1971-01-21
DE2036114C3 (de) 1979-09-13
FR2059541B1 (de) 1974-10-11
DE2036114B2 (de) 1979-01-18
IE34373B1 (en) 1975-04-16
US3670086A (en) 1972-06-13
GB1287673A (en) 1972-09-06
NL165653C (nl) 1981-05-15
FR2059541A1 (de) 1971-06-04
DE2036114A1 (de) 1971-02-04
NL7010558A (de) 1971-01-25
NL165653B (nl) 1980-12-15
ZA704419B (en) 1971-04-28
BE753710A (fr) 1970-12-31

Similar Documents

Publication Publication Date Title
CA964193A (en) Injectable compositions containing salts of l-tetramisole
CA955390A (en) Compositions containing aminopolyureylene resin
ZM4370A1 (en) Novel compositions of matter
CA978538A (en) Phosphonate compositions
CA923425A (en) Compositions containing garcinia acid
IL34089A (en) Pharmaceutical compositions containing penicillin or cephalosphorin derivatives
CA927079A (en) Pressure-oxidation of metal-sulfur-containing compositions
AU2085570A (en) Rubber-polyester compositions
CA979900A (en) Dialkyltin salts of substituted pyridine-1-oxides
AU450313B2 (en) Injectable oxytetracycline compositions
AU4960269A (en) Composition of matter
AU4067468A (en) Compositions of matter
AU453663B2 (en) Compositions containing n-dioctylethylene-triamines
AU437962B2 (en) Compositions of matter
CA777802A (en) Compositions of matter
AU456939B2 (en) Ester containing composition
AU1292270A (en) Improved beverage-forming compositions
AU453959B2 (en) Hydroxycitric acid derivatives containing compositions
AU449360B2 (en) Stabilizing composition
CA836563A (en) Composition of matter
CA796212A (en) Stabilized composition of quinonedihalimide compound
CA822730A (en) Compositions containing graphite
CA830476A (en) Therapeutic compositions containing aminocyclobutanols
AU1240870A (en) Injectable oxytetracycline compositions
CA829875A (en) Pharmaceutical compositions containing 1-methyl-4-phenyl-4-piperidinol